Lunai Bioworks Inc.
LNAI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001527728
No open-market purchases or sales by Lunai Bioworks Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $641.0K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Lunai Bioworks Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +1 vs. Q4 2022
- Shares held
- 3.30M
- −327.6K (−9.0%) vs. Q4 2022
- Total value
- $3.02M
- −$716.1K (−19.1%) vs. Q4 2022
- New holders
- 6
- 15 more added
- Sold out
- 5
- 13 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LNAI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $641.0K |
| Q1 2026 | 29 | $403.3K |
| Q4 2025 | 24 | $981.7K |
| Q3 2025 | 20 | $1.38M |
| Q2 2025 | 45 | $4.17M |
| Q1 2025 | 63 | $12.0M |
| Q4 2024 | 58 | $18.5M |
| Q3 2024 | 50 | $7.13M |
| Q2 2024 | 39 | $24.8M |
| Q1 2024 | 41 | $19.2M |
| Q4 2023 | 36 | $8.16M |
| Q3 2023 | 21 | $6.65M |
| Q2 2023 | 32 | $1.13M |
| Q1 2023 | 40 | $3.02M |
| Q4 2022 | 39 | $3.74M |
| Q3 2022 | 43 | $6.87M |
| Q2 2022 | 51 | $7.64M |
| Q1 2022 | 43 | $21.5M |
| Q4 2021 | 44 | $18.0M |
| Q3 2021 | 34 | $10.2M |
| Q2 2021 | 37 | $13.3M |
| Q1 2021 | 41 | $9.60M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Lunai Bioworks Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Group One Trading, L.P. | 69 | $63 | 0.00% | +69 | New |
| Citigroup Inc | 756 | $692 | 0.00% | −1,146−60.3% | Reduced |
| Ameritas Investment Partners, Inc. | 1,482 | $1.36K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 1,653 | $1.51K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,673 | $2.00K | 0.00% | −1,623−49.2% | Reduced |
| Amalgamated Bank | 3,821 | $3.00K | 0.00% | −458−10.7% | Reduced |
| Wells Fargo & Company | 3,473 | $3.18K | 0.00% | +3,473 | New |
| FMR LLC | 4,201 | $3.84K | 0.00% | +2,912+225.9% | Added |
| California State Teachers Retirement System | 7,347 | $6.72K | 0.00% | −542−6.9% | Reduced |
| UBS Group AG | 7,369 | $6.74K | 0.00% | +1,263+20.7% | Added |
| American International Group, Inc. | 9,537 | $8.73K | 0.00% | +190+2.0% | Added |
| Barclays PLC | 9,819 | $8.99K | 0.00% | +4,512+85.0% | Added |
| BNP Paribas Arbitrage, SA | 10,131 | $9.27K | 0.00% | +4,702+86.6% | Added |
| Alliancebernstein L.P. | 10,400 | $9.52K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 10,543 | $10.0K | 0.00% | +2,863+37.3% | Added |
| Allspring Global Investments Holdings, LLC | 12,650 | $11.6K | 0.00% | −23,618−65.1% | Reduced |
| Dimensional Fund Advisors LP | 12,742 | $11.7K | 0.00% | −12−0.1% | Reduced |
| Susquehanna International Group, LLP | 13,413 | $12.3K | 0.00% | +13,413 | New |
| Goldman Sachs Group Inc | 13,832 | $12.7K | 0.00% | +13,832 | New |
| JPMorgan Chase & Co | 15,138 | $14.0K | 0.00% | +3,952+35.3% | Added |
| Blair William & Co | 26,000 | $23.8K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 28,993 | $26.5K | 0.00% | +5,339+22.6% | Added |
| Rhumbline Advisers | 30,498 | $28.0K | 0.00% | +1,208+4.1% | Added |
| New York State Common Retirement Fund | 31,000 | $28.4K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 36,774 | $34.0K | 0.00% | −16,040−30.4% | Reduced |
| HRT Financial LP | 38,712 | $35.0K | 0.00% | +38,712 | New |
| Charles Schwab Investment Management Inc | 43,414 | $39.7K | 0.00% | −7,537−14.8% | Reduced |
| Deutsche Bank AG | 49,654 | $45.4K | 0.00% | +3,187+6.9% | Added |
| Bank of New York Mellon Corp | 55,005 | $50.3K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 56,152 | $51.4K | 0.00% | −33,515−37.4% | Reduced |
| Two Sigma Advisers, LP | 56,400 | $51.6K | 0.00% | −21,700−27.8% | Reduced |
| Natixis | 59,724 | $54.7K | 0.00% | +59,724 | New |
| Morgan Stanley | 75,634 | $69.2K | 0.00% | +4,294+6.0% | Added |
| Invesco Ltd. | 100,950 | $92.4K | 0.00% | −450−0.4% | Reduced |
| Nuveen Asset Management, LLC | 121,513 | $111.0K | 0.00% | −3,064−2.5% | Reduced |
| Northern Trust Corp | 163,553 | $149.7K | 0.00% | +2,337+1.4% | Added |
| State Street Corp | 307,408 | $281.3K | 0.00% | +1,800+0.6% | Added |
| Geode Capital Management, LLC | 318,855 | $291.8K | 0.00% | +720.0% | Added |
| Vanguard Group Inc | 322,276 | $294.9K | 0.00% | −436,427−57.5% | Reduced |
| BlackRock Inc. | 1,231,984 | $1.13M | 0.00% | +154,743+14.4% | Added |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −59,724−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −23,572−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −20,800−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |